Yuen S - Search Results

1

Investigator-initiated clinical trials in Malaysia and the role of the Clinical Research Centre of the Ministry of Health.

Sivanandam AF, Hon YK, Yuen S, Muninathan P, Goh PP, Lim TO. Sivanandam AF, et al. Among authors: yuen s. Med J Malaysia. 2010 Jun;65 Suppl A:138-42. Med J Malaysia. 2010. PMID: 21488475 Free article.

2

Development of a decision aid to support colorectal cancer screening: perspectives of Asians in an endemic urban community-a qualitative research study.

Yuen SWJ, Tay TY, Gao N, Tho NQ, Tan NC. Yuen SWJ, et al. BMC Med Inform Decis Mak. 2021 Mar 6;21(1):86. doi: 10.1186/s12911-021-01404-1. BMC Med Inform Decis Mak. 2021. PMID: 33676504 Free PMC article. Clinical Trial.

3

Pediatric trauma patients with isolated grade III blunt splenic injuries may be safely managed without intensive care unit admission.

Yuen S, Grigorian A, Swentek L, Qazi A, Jeng J, Kuza C, Inaba K, Nahmias J. Yuen S, et al. Surgery. 2024 May 31:S0039-6060(24)00206-X. doi: 10.1016/j.surg.2024.03.040. Online ahead of print. Surgery. 2024. PMID: 38824065

4

Safety and Efficacy of Immediate Hyperthermic Intravesical Chemotherapy Following Transurethral Resection of Bladder Tumour (I-HIVEC).

Wong CH, Ko IC, Leung DK, Yuen SK, Chan SY, Yee SC, Chiu PK, Ng CF, Teoh JY. Wong CH, et al. Among authors: yuen sk. Eur Urol Oncol. 2024 May 27:S2588-9311(24)00136-6. doi: 10.1016/j.euo.2024.05.006. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38806344

5

Could Use of a Flexible and Navigable Suction Ureteral Access Sheath Be a Potential Game-changer in Retrograde Intrarenal Surgery? Outcomes at 30 Days from a Large, Prospective, Multicenter, Real-world Study by the European Association of Urology Urolithiasis Section.

Gauhar V, Traxer O, Castellani D, Sietz C, Chew BH, Fong KY, Hamri SB, Gökce MI, Gadzhiev N, Galosi AB, Yuen SKK, El Hajj A, Ko R, Zawadzki M, Sridharan V, Lakmichi MA, Corrales M, Malkhasyan V, Ragoori D, Soebhali B, Tan K, Chai CA, Tursunkulov AN, Tanidir Y, Persaud S, Elshazly M, Kamal W, Tefik T, Shrestha A, Tiong HC, Somani BK. Gauhar V, et al. Among authors: yuen skk. Eur Urol Focus. 2024 May 23:S2405-4569(24)00073-7. doi: 10.1016/j.euf.2024.05.010. Online ahead of print. Eur Urol Focus. 2024. PMID: 38789313 Free article.

6

Scoping Review of Experimental and Clinical Evidence and Its Influence on Development of the Suction Ureteral Access Sheath.

Yuen SKK, Traxer O, Wroclawski ML, Gadzhiev N, Chai CA, Lim EJ, Giulioni C, De Stefano V, Nedbal C, Maggi M, Sarica K, Castellani D, Somani B, Gauhar V. Yuen SKK, et al. Diagnostics (Basel). 2024 May 16;14(10):1034. doi: 10.3390/diagnostics14101034. Diagnostics (Basel). 2024. PMID: 38786332 Free PMC article. Review.

7

What makes advance care planning discussion so difficult? A systematic review of the factors of advance care planning in healthcare settings.

Suen MHP, Chow AYM, Woo RKW, Yuen SK. Suen MHP, et al. Among authors: yuen sk. Palliat Support Care. 2024 May 20:1-14. doi: 10.1017/S1478951524000464. Online ahead of print. Palliat Support Care. 2024. PMID: 38766704 Review.

8

Perioperative renal function change and oncological outcomes of radical nephroureterectomy in patients with upper tract urothelial carcinoma: A multicenter retrospective study.

Muramoto K, Urabe F, Koike Y, Yamamoto S, Suzuki H, Miyajima K, Fukuokaya W, Iwatani K, Imai Y, Igarashi T, Mori K, Aikawa K, Kimura S, Tashiro K, Yamada Y, Sasaki T, Sato S, Yuen SKK, Shimomura T, Furuta A, Tsuzuki S, Miki J, Kimura T; JIKEI-YAYOI Collaborative Group. Muramoto K, et al. Among authors: yuen skk. Urol Oncol. 2024 May 9:S1078-1439(24)00421-6. doi: 10.1016/j.urolonc.2024.04.001. Online ahead of print. Urol Oncol. 2024. PMID: 38729868

9

Transurethral water vapour thermal therapy for benign prostatic hyperplasia under local anaesthesia alone: initial experience in Chinese patients.

Lo KL, Mok A, Ko ICH, Yuen SKK, Chiu PKF, Ng CF. Lo KL, et al. Among authors: yuen skk. Hong Kong Med J. 2024 May 10. doi: 10.12809/hkmj2210330. Online ahead of print. Hong Kong Med J. 2024. PMID: 38725395 Free article. No abstract available.

10

Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma.

Yuen S, Phillips TJ, Bannerji R, Marlton P, Gritti G, Seymour JF, Johnston A, Arthur C, Dodero A, Sharma S, Hirata J, Musick L, Flowers CR. Yuen S, et al. Am J Hematol. 2024 May 3. doi: 10.1002/ajh.27341. Online ahead of print. Am J Hematol. 2024. PMID: 38700035

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

624 results

Search Page